
Synthetic Biology: Global Markets
Description
Synthetic Biology: Global Markets
Report Scope:
The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-free production systems), enabling technologies (e.g., DNA sequencing, DNA synthesis, gene editing, bioinformatics, specialty media) and enabled technologies (e.g., healthcare, industrial chemicals, consumer products, food and beverage, agriculture) that are already commercialized or are forecast to be commercialized through 2029.
Key synthetic biology technologies and products are analyzed to determine present and future market status, as well as forecasted growth from 2024 through 2029. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces is also provided.
BCC Research examines the synthetic biology industry by market segment, including DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, and software. The market is also analyzed by end users, including agriculture, consumer products, cosmetics and skin care, food and beverage, healthcare, and industrial chemicals.
By geographical region, the market is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Report Includes:
-50 data tables and 45 additional tables
An analysis of the global markets for synthetic biology products and technologies
Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the current market size and revenue prospects, along with market share analysis by product type, end-user industry and region
Facts and figures pertaining to the market drivers and challenges, innovations, technologies, industry regulations, and the influence of macroeconomic factors
Identification of core synthetic biology products, key enabling technologies, commercial opportunities for product development, and competitive strategies
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, the ESG practices of leading companies and their ESG scores
An analysis of patents granted for synthetic biology technologies, liquid biopsy and sequencing, and gene editing
Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and venture funding outlook
Profiles of the market leaders, including Ginkgo Bioworks, Amyris, Twist Bioscience, Codexis Inc., and Thermo Fisher Scientific Inc.
Companies Mentioned
Agilent Technologies Inc.
Amyris
Codexis Inc.
Eurofins Scientific
Genscript
Ginkgo Bioworks
Merck Kgaa
Thermo Fisher Scientific Inc.
Twist Bioscience
Viridos
Table of Contents
137 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Overview
- Value Chain Analysis
- Regulatory Framework
- Regulation of GEMs in the United States
- Impacts of Synthetic Biology on Biodiversity Conservation
- Direct Impacts
- Indirect Impacts
- Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Various Applications of Synthetic Biology in Diverse Fields
- Increasing Funding for Research and Development
- Declining Cost of DNA Sequencing
- Continuous Innovations in the Synthetic Biology Field
- Market Restraints
- Biosafety, Biosecurity, and Ethical Issues
- Market Opportunities
- Increasing Demand for Fuel Alternatives
- Use of Machine Learning in Synthetic Biology
- Chapter 4 Emerging Trends and Patent Analysis
- Emerging Trends
- CRISPR-Cas Systems
- Gene Drives
- Expanded Genetic Code
- Optogenetics
- Synthetic Genomics
- Cell-Free System
- Microbiome Engineering
- Patent Analysis
- Select Patent Grants
- Patent Review
- Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis, by Product Type
- Enabled Products
- Enabling Products
- Biologic Components
- Integrated Systems
- Market Analysis, by End User
- Enabled Product, by End User
- Enabling Product, by End User
- Biologic Components, by End User
- Integrated Systems, by End User
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 6 Competitive Intelligence
- Company Share Analysis
- Investment in Industry
- Chapter 7 Sustainability in Synthetic Biology Market: ESG Perspective
- Overview
- ESG Trends in the Biotechnology Industry
- ESG Risks and Challenges
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance and Ethical Considerations
- Chapter 8 Appendix
- Methodology
- Sources
- Acronyms
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- AMYRIS
- CODEXIS INC.
- EUROFINS SCIENTIFIC
- GENSCRIPT
- GINKGO BIOWORKS
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
- TWIST BIOSCIENCE
- VIRIDOS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.